产品中心 抗体 其他一抗

所有图片(1/1)

GCLC Recombinant Rabbit mAb (S-2198-137)

Glutamate--cysteine ligase catalytic subunit,GCS heavy chain,Gamma-ECS,Gamma-glutamylcysteine synthetase,GLCL,GLCLC

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6231
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    GCLC
  • 分子别名

    Glutamate--cysteine ligase catalytic subunit; GCS heavy chain; Gamma-ECS; Gamma-glutamylcysteine synthetase; GLCL; GLCLC
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Mitochondrion
  • Accession

    P48506
  • 克隆号

    S-2198-137
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu
  • 阳性样本

    MCF7, A549
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu
背景介绍
  • The GCLC (glutamate–cysteine ligase catalytic subunit) protein is the catalytic subunit of glutamate cysteine ligase (GCL, formerly γ-glutamylcysteine synthetase), the enzyme that catalyzes the first, rate-limiting step in glutathione (GSH) synthesis by forming γ-glutamylcysteine from glutamate and cysteine using ATP; this ~73 kDa subunit contains all substrate and cofactor binding sites necessary for catalysis, while the regulatory GCLM subunit increases its catalytic efficiency when complexed in the holoenzyme, and mutations in GCLC are associated with hemolytic anemia due to GSH deficiency and susceptibility to myocardial infarction [^5].

  • 免疫印迹

    • WB result of GCLC Recombinant Rabbit mAb
      Primary antibody: GCLC Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: A172 whole cell lysate 20 µg
      Lane 2: MCF7 whole cell lysate 20 µg
      Lane 3: A549 whole cell lysate 20 µg
      Low expression control: A172 whole cell lysate
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 73 kDa
      Observed MW: 70 kDa

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)